Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Twist Bioscience Corp (TWST) vs Western Alliance Bancorporation (WAL) Price & Performance

Twist Bioscience CorpTrade
Western Alliance BancorporationTrade

Price performance (Past 24H)

Key statistics

Twist Bioscience Corp vs Western Alliance Bancorporation — how do they compare? Twist Bioscience Corp trades at $122.96 (market cap $7.82B), while Western Alliance Bancorporation trades at $81.46 (market cap $8.78B). The key difference: Twist Bioscience Corp and Western Alliance Bancorporation are close in size by market cap, and Western Alliance Bancorporation pays a 2.09% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.

TWSTWAL
Market Cap
$7.82B$8.78B
Sector
HealthFinancials
52-Week High
$124.88$96.08
52-Week Low
$24.16$66.70
Enterprise Value
$7.75B
Dividend Yield
2.09%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Twist Bioscience Corp

Twist Bioscience (TWST) trades at $115.67, up 6.04% in the last session, with bullish technical signals from moving averages and a recent analyst upgrade. Revenue growth is strong, with fiscal 2026 Q3 revenue up 23% year-over-year to $118.4 million, though the company remains unprofitable with negative net income margins. A recent $300 million public offering at $96 per share indicates capital raising for expansion.

The outlook is mixed: robust revenue growth and high analyst buy ratings (78.57%) support upside potential, but persistent losses, cash burn, and high valuation ratios pose significant risks. Investors should weigh growth prospects against financial sustainability concerns.

Western Alliance Bancorporation

Western Alliance Bancorporation (WAL) trades at $81.39, up 0.06% on the day, with a neutral technical signal and bullish moving averages. The stock shows strong fundamentals with a P/E of 9.08, net income margin of 25.43%, and consistent earnings beats in recent quarters. Recent developments include the launch of WA VenueX, a digital asset liquidity platform, and recognition as Arizona's top bank by Forbes in 2026.

Outlook remains positive with a consensus price target of $93.86, implying 15% upside, supported by 79% analyst buy ratings. Risks include negative operating cash flow and institutional selling, but revenue growth and profitability trends provide a solid foundation for investor confidence.

Returns comparison

Trailing returns across standard periods

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST

About Western Alliance Bancorporation

Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.

Read more on WAL